Skip to the page content
Your donations
Passes our checks

Prevent Alzheimers Disease 2020

EIN 27-0425749 · Potomac, MD

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthFair69 out of 100GovernanceGood73 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

PAD2020 was created to rally national support and focus on increasing research and knowledge to prevent Alzheimers disease and other neurodegenerative diseases that affect the memory movement or mood of individuals.

Income
$442,190
Spending
$425,745
Spent on programs
74%
Reserves
0.5 months of spending
Largest source of income
donations and private grants, 100%
Employees
0
Volunteers
80

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Fair: 69 out of 100. Higher than 24% of charities in its peer group (medical research, $250k to $1m).

  • Reserves

    4 of 35

    Spendable reserves would cover 0.5 months of spending.

  • Debt

    20 of 20

    It owes 0% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 4% of income.

  • Income trend

    15 of 15

    Income rose 24% on the year before.

  • Spending floor

    15 of 15

    74% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Good: 73 out of 100. Higher than 47% of charities in its peer group (medical research, $250k to $1m).

  • Independent board

    18 of 25

    4 of 4 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (3)
  1. $225,447 spent. In the United States two major regulatory hurdles must be overcome for affordable and accessible tools to be developed and deployed for diagnosing assessing and monitoring those at risk of or with cognitive disorders. The FDA and CMS have two different regulatory missions. Developers of new clinical interventions and tools must demonstrate the effectiveness and clinical relevance of their outcomes. They also need to consider factors such as reimbursement and quality. To address these challenges the Campaign to Prevent Alzheimers Disease launched a task force to review recommendations and develop new project proposals. The group titled The Campaign to Prevent Alzheimers Disease Work Group on Community-Based Detection and Assessment of Cognitive Decline, identified different pathways of community-based detection using electronic health records from different international healthcare systems to detect and monitor individuals with early cognitive impairment. The recommendations aim to guide future sustainability activities public policy campaigns and implementation pilots.
  2. $41,514 spent. Alzheimers disease poses a significant burden on a global scale which has led to an enormous investment in research to find a cure. However despite these efforts there are very few medications available for people with dementia. The search for new interventions for Alzheimers disease is challenging because the exact relationship between the symptoms of the disease and its neurobiology is not yet fully understood. The diseases heterogeneity complex biological and environmental interactions multiple nonlinear timescales and a lack of modeling systems to integrate complex relationships further complicate this effort. To address these challenges the Calcium System Theory of Alzheimers Disease CAST-AD workgroup aims to design a unified systems theory. The group aims to create new foundational models to study protein dynamics and aggregation in neurodegenerative diseases. These models will be trained using supercomputing and hybrid super- and quantum-computing to simulate large data sets of proteins. The project will establish and validate foundational models using proteins such as bioluminescent enzymes to provide an easy functional readout. The group will then apply these models to crucial proteins and peptides involved in neurodegenerative diseases.
  3. $49,061 spent. Brain vascular diseases are linked to the onset of dementia. PAD 20 20 coordinated a global task force to assess the efficacy of utilizing approved vascular health interventions to prevent or treat dementia. Evidence shows that modifying lifestyle factors such as physical activity healthy diet and proper sodium intake can improve vascular health and offer an opportunity for brain health. The initiative aims to identify tangible opportunities to provide financial or technical resources to sustain multi-year activities and evaluate approaches that may accelerate the development of new interventions. The project will focus on developing strategies to provide affordable accessible and equitable dementia prevention through widely prescribed medications for various vascular and metabolic disorders. There is a clear need for robust clinical evidence to support this public health approach.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since November 2009.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.